Surgical Management of Hepatic Hemangiomas: a Multi-Institutional Experience
John T. Miura,Albert Amini,Ryan Schmocker,Shawnn Nichols,Daniel Sukato,Emily R. Winslow,Gaya Spolverato,Aslam Ejaz,Malcolm H. Squires,David A. Kooby,Shishir K. Maithel,Aijun Li,Meng-Chao Wu,Juan M. Sarmiento,Mark Bloomston,Kathleen K. Christians,Fabian M. Johnston,Susan Tsai,Kiran K. Turaga,Allan Tsung,Timothy M. Pawlik,T. Clark Gamblin
DOI: https://doi.org/10.1111/hpb.12291
IF: 3.842
2014-01-01
HPB
Abstract:BACKGROUND:The management of hepatic hemangiomas remains ill defined. This study sought to investigate the indications, surgical management and outcomes of patients who underwent a resection for hepatic hemangiomas.METHODS:A retrospective review from six major liver centres in the United States identifying patients who underwent surgery for hepatic hemangiomas was performed. Clinico-pathological, treatment and peri-operative data were evaluated.RESULTS:Of the 241patients who underwent a resection, the median age was 46 years [interquartile range (IQR): 39-53] and 85.5% were female. The median hemangioma size was 8.5 cm (IQR: 6-12.1). Surgery was performed for abdominal symptoms (85%), increasing hemangioma size (11.3%) and patient anxiety (3.7%). Life-threatening complications necessitating a hemangioma resection occurred in three patients (1.2%). Clavien Grade 3 or higher complications occurred in 14 patients (5.7%). The 30- and 90-day mortality was 0.8% (n = 2). Of patients with abdominal symptoms, 63.2% reported improvement of symptoms post-operatively.CONCLUSION:A hemangioma resection can be safely performed at high-volume institutions. The primary indication for surgery remains for intractable symptoms. The development of severe complications associated with non-operative management remains a rare event, ultimately challenging the necessity of additional surgical indications for a hemangioma resection.